PCI High Potent Manufacturing
LB Bohle – 10.06.2025
Temax_Krautz

Current Edition

Current Edition

Subsection - CDMO

Examining how innovative technologies, integrated manufacturing approaches and AI are shaping manufacturing.

Continue reading

Subsection - Injectables

Exploring advances in injectable drug delivery and sterile manufacturing, designed to improve patient-centric delivery.

Continue reading

Subsection - Neurodegenerative Diseases

Exploring emerging approaches to neurodegenerative disease research and treatment.

Continue reading

Subsection - Nasal & Pulmonary

Highlighting how advances in nasal and pulmonary drug delivery, formulation, devices and analytics are enabling more complex therapies.

Continue reading

Advertisement

CPHI 2027
DDL 2026

Advertisement

Nipro August 26

Advertisement

Merxin March 2026

Advertisement

Aurisco 300×250

Advertisement

Lifecore Biomedical
News

Complex System for Blending, Sieving, Granulation and Tableting

System Delivered to Leading Pharmaceutical Company L.B. Bohle delivered an all-in-one solution for blending, sieving, wet granulation and tableting of solids to...
Continue Reading →
News

Novartis’ radioligand therapy granted US Breakthrough Therapy Designation

Swiss pharma company Novartis has scored a Breakthrough Therapy Designation (BTD) from the US Food and Drug Administration for its investigational radioligand therap...
Continue Reading →
News

EU green lights AZ, MSD’s rare disease therapy Koselugo

The European Commission (EC) has granted AstraZeneca (AZ) and MSD’s Koselugo (selumetinib) a conditional approved for the treatment of children with symptomatic, ino...
Continue Reading →
News

US approves Pradaxa as oral blood thinning med for children

The Food and Drug Administration (FDA) has approved Boehringer Ingelheim’s Pradaxa as the first oral blood thinning medication to treat children aged three months to...
Continue Reading →
News

Takeda and tech start-up partner on biopharmaceuticals

A joint project between Takeda, the Research Center Pharmaceutical Engineering (RCPE), the technology company InSilicoTrials and the University of Graz will allow on...
Continue Reading →
News

ABPI forms new Patient Advisory Council

The Association of the British Pharmaceutical Industry (ABPI) is seeking six senior leaders from across the patient charity sector to join a newly formed Patient Adv...
Continue Reading →
News

FDA approves Bayer’s Astepro for OTC use in US

The U.S. Food and Drug Administration (FDA) has approved Bayer’s nasal antihistamine for non-prescription use through the process of partial prescription to non-pres...
Continue Reading →
News

Nemera breaks ground in Brazil through Milfra acquisition

With this acquisition, Nemera establishes an operational footprint in Brazil and expands its product and services offering to better serve the pharmaceutical industr...
Continue Reading →
News

Opdivo plus Yervoy scores NICE backing for certain bowel cancer patients

Bristol Myers Squibb’s (BMS) immunotherapy combination Opdivo plus Yervoy has been recommended by the National Institute for Health and Care Excellence (NICE) for th...
Continue Reading →
News

Biogen’s inherited eye disease gene therapy misses the mark in late-stage trial

Biogen has announced that a late-stage trial of its gene therapy timrepigene emparvovec did not meet its primary and key secondary endpoints in patients with the rar...
Continue Reading →

Advertisement

MedPharm 16/07

Advertisement

Biopharma group march 2026

Advertisement

Silgan March 2026

Advertisement

Terumo 06/26

Advertisement

Scott Pharma – 25.03.2025

Advertisement

Bespak

Advertisement

Solstice

Advertisement

Bachem skyscraper
Tjoapack
Aptar – 08/01/2026